Generic Name: acetylcysteine injection
Date of Approval: January 23, 2004
Company: Cumberland Pharmaceuticals
Treatment for: Acetaminophen Overdose
FDA approves Acetadote
Acetadote (acetylcysteine) injection will be used in an emergency room setting to prevent or lessen potential liver damage resulting from an overdose of acetaminophen, the leading cause of drug toxicity in the United States. According to the FDA, more than 56,000 emergency room visits and 100 deaths occur each year due to unintentional overdoses of acetaminophen, a common ingredient in many over-the-counter painkillers. Acetadote, administered intravenously within 8 to 10 hours after ingestion of a potentially hepatotoxic quantity of acetaminophen, is indicated to prevent or lessen hepatic injury.
What is Acetadote
Acetadote is the first injectable treatment for acetaminophen overdose available in the United States.
Source: Cumberland Pharmaceuticals
More Acetadote resources
- Acetadote Prescribing Information (FDA)
- acetylcysteine solution MedFacts Consumer Leaflet (Wolters Kluwer)
- Acetylcysteine Monograph (AHFS DI)
- acetylcysteine Inhalation, oral/nebulization Advanced Consumer (Micromedex) - Includes Dosage Information
- Mucomyst Prescribing Information (FDA)